Global Ophthalmology Drugs & Devices Market Professional Survey Report 2019
SKU ID : QYR-14651065 | Publishing Date : 04-Sep-2019 | No. of pages : 119
Ophthalmology is a branch of medicine and surgery (both methods are used) that deals with the anatomy, physiology and diseases of the eyeball and orbit. Ophthalmic Equipment are the tool used for ophthalmology.
The growth of this market is primarily due to the rapid growth in the geriatric population, rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment.
The global Ophthalmology Drugs & Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ophthalmology Drugs & Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ophthalmology Drugs & Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ophthalmology Drugs & Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ophthalmology Drugs & Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott
Alcon
Allergan
Bausch & Lomb
Carl Zeiss Meditec
Ellex
Essilor
Hoya
Iridex
Johnson & Johnson
Merck & Co.
Nidek Co.
Santen Pharmaceutical
Novartis
Pfizer
Roche Holding
Staar Surgical
Topcon
Ziemer Ophthalmic Systems
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Diagnostic and monitoring devices
Surgical devices
Vision care
Drugs
Segment by Application
Cataract
Glaucoma
Refractive error
Vitreoretinal
The growth of this market is primarily due to the rapid growth in the geriatric population, rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment.
The global Ophthalmology Drugs & Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ophthalmology Drugs & Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ophthalmology Drugs & Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ophthalmology Drugs & Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ophthalmology Drugs & Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott
Alcon
Allergan
Bausch & Lomb
Carl Zeiss Meditec
Ellex
Essilor
Hoya
Iridex
Johnson & Johnson
Merck & Co.
Nidek Co.
Santen Pharmaceutical
Novartis
Pfizer
Roche Holding
Staar Surgical
Topcon
Ziemer Ophthalmic Systems
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Diagnostic and monitoring devices
Surgical devices
Vision care
Drugs
Segment by Application
Cataract
Glaucoma
Refractive error
Vitreoretinal
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.